Hong Kong Stock Connect Shareholding Disclosures | August 18
Stock News
Aug 18
According to the latest disclosure filing, Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (01349) reported a change in shareholder equity on August 18, 2026.
The filing details that Wang Haibo, holding a long position, reduced his stake from 38,746,500 shares to 30,997,200 shares. This adjustment brings his current shareholding ratio to 4.36%, down from the previous 5.45%.
It is important to note that fluctuations in share counts may result from corporate actions such as rights issues, share consolidations, or stock splits. Investors are advised to verify these changes against the actual corporate events to ensure accurate interpretation.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.